Content with tag winter 2015 .

Specialty Drug Pricing and Channeling

For years pharmaceutical manufacturers have defended the high cost of newly approved medications with explanations about the skyrocketing costs of research and development. In the current...

MedMatters

Latest announcements and news from MedImpact. Updated December 2015.

Managing Hepatitis C: The High Price of Not Prioritizing Therapy

Prescription therapy for hepatitis C has improved in cure rates, and significantly increased in cost. The impact of the increase highlights the need for budget impact modeling for new, innovative...

MedImpact: The Right Partner for Managed Medicaid

State budgets are under significant pressure with the rising cost of healthcare, and Medicaid typically consumes up to 20% to 25% of state budgets. In many states, Medicaid is the largest...